“… Patent, of Warner-Lambert’s claim against Actavis for infringement of claims 1 and 3 of the Patent and of Actavis’ claim against Pfizer for groundless threats [2015] EWHC 2548 (Pat), [2016] RPC 3 (“Warner-Lambert V”). In that judgment I held that:…”
“…r taking the lead: see e.g. KCI Licensing Inc v Smith & Nephew plc [2010] EWHC 1487 (Pat), [2010] FSR 31 at [103] and Generics (UK) Ltd v Warner-Lambert Co LLC [2015] EWHC 2548 (Pat), [2016] RPC 3 at [118]-[119].…”